To determine the incidence and outcome of hepatic veno-occlusive disease (VOD) after
blood or marrow transplantation (BMT), we prospectively evaluated all consecutive patients …

This retrospective cohort study of 462 consecutive adult allogeneic and autologous blood or
marrow transplantation (BMT) patients compared the incidence of hepatic veno-occlusive …

The clinical syndrome of veno‐occlusive disease (VOD) after hemopoietic cell
transplantation is characterised by jaundice, painful liver enlargement, and fluid retention …

Review of 235 consecutive patients undergoing bone marrow transplantation was
performed in order to define the clinical syndrome of venoocclusive disease of the liver …

Occurrence of hepatic veno-occlusive disease (VOD) has been reported in up to 60% of
patients following stem cell transplantation (SCT). However, the incidence varies widely …

Veno‐occlusive disease (VOD) is a major cause of toxic death after autologous bone
marrow transplantation (ABMT). We studied the potential role of continuous administration of …

Hepatic veno-occlusive disease (VOD) is a major regimen-related toxicity after bone marrow
transplantation (BMT). Endothelial injury, leading to deposition of coagulation factors within …

Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome
(SOS), can develop in a subset of patients, primarily after myeloablative hematopoietic stem …

Objective: To determine the incidence and clinical course of veno-occlusive disease of the
liver (VOD) after bone marrow transplantation and to analyze risk factors for severe VOD …

The clinical syndrome of VOD is a frequent cause of nonrelapse mortality among patients
receiving high-dose cytoreductive regimens. Patients likely to develop VOD have existing …